AstraZeneca PLC operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares AstraZeneca PLC with three other
pharmaceutical manufacturers in Europe:
Novo Nordisk As
sales of 126.95 billion Danish Kroner [US$20.07 billion]
of which 85%
was Diabetes and obesity),
(37.37 billion Euros [US$43.91 billion]
of which 69%
was Pharmaceuticals), and
based in GERMANY
(17.53 billion Euros [US$20.60 billion]
of which 43%
was Life Science).
During the second
quarter of 2021, sales at AstraZeneca PLC totalled
an increase of 21.4%
from the £4.86 billion in sales at the company during the second quarter of 2020.
During the first two
quarters of 2021, sales totalled £11.20 billion, which is
than through the first two quarters of 2020.
During the year ended December of 2020, sales at
AstraZeneca PLC were £20.59 billion (US$28.37 billion).
increase of 8.0%
versus 2019, when the company's sales were £19.06 billion.